1. Genome-Wide Association Study Identifies Multiple Genetic Loci for Activated Partial Thromboplastin Time and Prothrombin Time
- Author
-
Christine Schwienbacher, James S. Pankow, Alan J. Gow, Gordon D.O. Lowe, Eric Boerwinkle, Aaron R. Folsom, Claudia B. Volpato, David J. Porteous, Cosetta Minelli, Peter M. Visscher, Saonli Basu, Yoav Ben-Shlomo, Gail Davies, Lorna M. Lopez, John M. Starr, Albert Tenesa, Ann Rumley, Peter P. Pramstaller, Weihong Tang, Ian J. Deary, Martin Gögele, Andrew A. Hicks, Mary Cushman, and John Yarnell
- Subjects
Genetics ,Prothrombin time ,education.field_of_study ,Candidate gene ,medicine.diagnostic_test ,Immunology ,Population ,Genome-wide association study ,Single-nucleotide polymorphism ,Cell Biology ,Hematology ,Biology ,medicine.disease ,Biochemistry ,Minor allele frequency ,Factor V Leiden ,medicine ,education ,Partial thromboplastin time - Abstract
Abstract 4222 Background: Activated partial thromboplastin time (aPTT) and prothrombin time (PT) are commonly used to screen for coagulation factor deficiencies. Shorter aPTT is also a risk marker for incident and recurrent venous thromboembolism (VTE). Genetic factors influencing aPTT and PT are not well understood. So far only one genome-wide association study (GWAS) has been reported for aPTT in 1,477 participants and none for PT. Methods: We conducted a GWAS for the aPTT in 9,240 European Americans (EAs) from the Atherosclerosis Risk in Communities (ARIC) study and for PT in 1,221 EAs from the Genetic Study of Three Population Microisolates in South Tyrol (MICROS). Replication was assessed by in silico analysis in MICROS (aPTT, n=1,215) and the Lothian Birth Cohorts (LBC) (LBC1936 (aPTT and PT, n=925-989), LBC1921 (aPTT, n=445)), and by de novo genotyping in the Caerphilly study (aPTT, n=882). Subjects on anticoagulants were excluded. Genotyping was conducted with the Affymetrix single nucleotide polymorphism (SNP) array 6.0 or Illumina HumanHap300/370 and imputed to ∼2.5 million HapMap SNPs. SNPs with imputation quality score < 0.3 or minor allele frequencies ≤1% were excluded from data analysis. The imputed SNP dosages were analyzed in linear regression adjusted for age, sex, and field center, where applicable. Results: Five loci were associated with aPTT at genome-wide significance of p Conclusions: In this large GWAS, six of the nine novel loci associated with the aPTT and PT are coagulation-related and the other three (NSD1, C6orf10, and AGBL1) are new candidate genes not directly involved in coagulation. The C6orf10 gene interacts with TNF-a at the transcription level and was previously associated with inflammatory diseases. These findings may be relevant to the prevention and treatment of coagulation disorders including VTE. Disclosures: No relevant conflicts of interest to declare.
- Published
- 2010